Hospital Universitario Marqués de Valdecilla. Santander

Santander

0 studies enrolling now · 2 studies all time

What they study most

HPV16 Positive, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Oropharynx

Studies at this site

• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC — Status unconfirmed